Search clinical trials for: RO5093151

Total 5 results

Hoffmann-La Roche

Completed

A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma

Hypertension, Glaucoma, Open-Angle

United States, Bulgaria, Czech Republic, Hungary
Hoffmann-La Roche

Completed

A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease

Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD

Germany, Austria
Hoffmann-La Roche

Completed

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Diabetes Mellitus Type 2

Austria, Germany, United States
Hoffmann-La Roche

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).

Glaucoma

United States, Singapore
Hoffmann-La Roche

Completed

A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers

Healthy Volunteer

United States

3

Subscribe